Clinical trials: Time in Range, open to volunteers
Type2diabetes, Pregnancy Related
Real Time Continuous Glucose Monitoring System in T2DM With Pregnacy
The prevalence of type 2 diabetes mellitus (T2DM) in women of childbearing age is increasing rapidly, and low glucose compliance leads to an increased risk of adverse pregnancy outcomes for mothers and infants during pregnancy in…
- Conditions
- Type2diabetes, Pregnancy Related, Continuous Glucose Monitoring, Time in Range
- Trial name
- NCT05947916
- Testing
- Real-time Continuous Glucose Monitoring System
- Where
- China
- Volunteers
- 240 people
- Sponsor
- Peking University Third Hospital
Diabetes During Pregnancy
Fueling Labor: Protein Supplementation for Intrapartum Glucose Control
The goal of this study is to learn if high-protein drinks during labor can improve blood sugar control in pregnant women with insulin-treated diabetes.
- Trial name
- NCT07571343
- Testing
- High-Protein Beverage (Genius Gourmet Sparkling Protein Water), Standard Clear Liquid Diet, Continuous Glucose Monitoring (Abbott Freestyle Libre)
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Medical College of Wisconsin
AF
Warfarin Quality, Adherence, Range, Determinants, and Events in Egyptian Rheumatic Heart Disease and Atrial Fibrillation
No Egyptian study has systematically quantified TTR, identified its predictors, or linked anticoagulation quality to clinical outcomes in the RHD-AF population.
- Trial name
- WARDEN-Egypt (NCT07826299)
- Testing
- INR, Time in Therapeutic Range, International Normalized Ratio (INR)
- Where
- Egypt
- Volunteers
- 90 people
- Sponsor
- Assiut University
Diabetes in Pregnancy
Effects of Moderate Carbohydrate Consumption on Metabolic and Obstetric Outcomes in Pregnant Women With Insulin-treated Diabetes- A Randomized Controlled Trial
Diabetes during pregnancy increases maternal and fetal complications, necessitating optimal glycemic control. The standard care diet (SCD, ≥175g/day carbohydrate) lacks robust evidence, particularly for pregnancies requiring…
- Trial name
- NCT06355154
- Testing
- Nutritional intervention
- Where
- Israel
- Volunteers
- 120 people
- Sponsor
- Hadassah Medical Organization
Type 1 Diabetes (T1D), Glycemic Control for Diabetes Mellitus
Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
The purpose of this study is to see if the study drug CIR-0602K will improve glucose time-in-range and/or lower total daily insulin dose in people with type 1 diabetes who are using closed-loop automated insulin delivery.
- Conditions
- Type 1 Diabetes (T1D), Glycemic Control for Diabetes Mellitus, Insulin, Ketones
- Trial name
- WBH003 (NCT07186660)
- Testing
- CIR-0602K
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- University of Virginia
Type 2 Diabetes
Real-world Effects of Using Intermittently Scanned Continuous Glucose Monitoring and Pharmacist-led Coaching on the Management of Type 2 Diabetes Among Adults Not Using Insulin (REAL isCGM T2D)
The goal of this prospective study is to evaluate diabetes outcomes after initiating second generation intermittently scanned continuous glucose monitoring (isCGM) plus one pharmacist consultation session compared with capillary…
- Trial name
- REAL isCGM T2D (NCT06837103)
- Testing
- Intermittently Scanned Continuous Glucose Monitor
- Where
- Canada
- Volunteers
- 250 people
- Sponsor
- LMC Diabetes & Endocrinology Ltd.
Type 2 Diabetes, Obesity & Overweight
Influence of the Use of Specific Nutritional Formulas on Time in Range in Patients With Type 2 Diabetes
Who can participate? Individuals may be eligible to join this study if they meet the following criteria: Are 18 years or older. Have Type 2 diabetes with an A1c level higher than 7%.
- Conditions
- Type 2 Diabetes, Obesity & Overweight, Time in Range
- Trial name
- NCT07666581
- Testing
- Glucerna, Caloric restriction
- Where
- Colombia
- Volunteers
- 198 people
- Sponsor
- Hospital Universitario San Ignacio
Diabetes Mellitus, Type 1
Study of the Impact of PROximity Support for Patients With Type 1 DIABetes Treated With an Insulin Pump or Closed Loop.
Amidst medical innovations, many Type 1 diabetes patients using advanced therapy show improved control but still suffer from diabetes-related distress.
- Trial name
- PRO-DIAB-1 (NCT06050642)
- Testing
- enhanced care model provided by Timkl, a home support provider
- Where
- France
- Volunteers
- 340 people
- Sponsor
- timkl
Diabetes Mellitus, Diabetes Mellitus ( Type 1 and Type 2)
PMCF Study of GX-01S CGM in Adults With Diabetes
This clinical study evaluates the GX-01S Continuous Glucose Monitoring (CGM) System in adults with Type 1 or Type 2 diabetes. CGM systems measure glucose levels continuously throughout the day, providing real-time information…
- Trial name
- PROMISE-GX (NCT07802327)
- Testing
- GX-01S Continuous Glucose Monitoring System
- Volunteers
- 100 people
- Sponsor
- MicroTech Medical（Hangzhou）Co.,Ltd.
Type 1 Diabetes Mellitus, Insulin Pump
Evaluating an Insulin Pump for Time in Range (TIR) in Patients with Type 1 Diabetes
Diabetes mellitus is a metabolic disorder caused by genetic, environmental changes, mental health issues, immune disorders, and other factors.
- Conditions
- Type 1 Diabetes Mellitus, Insulin Pump, Time in Range
- Trial name
- NCT06741943
- Testing
- insulin pump (model: AR-B200A)
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Tao Yuan，MD